Aeglea BioTherapeutics
is building a potentially best in class pipeline with next generation and rational combinations strategy target program discovery clinical | Aeglea BioTherapeutics
Deck date
June 2023
Slide
36 of 50
Similar slides by Aeglea BioTherapeutics
Investor Presentation
September 2023
Investor Presentation
September 2023
Investor Presentation
September 2023
Investor Presentation
September 2023
Related slides by other companies
Investor Presentation
January 2024
Investor Presentation
October 2023
Results
March 2022
Investor Day
December 2023
Other recent decks by Aeglea BioTherapeutics
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies